Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study

OBJECTIVE: We aimed to establish and validate nomograms to evaluate overall survival (OS) and cancer-specific survival (CSS) in patients with metastatic renal cell carcinoma (MRCC). METHODS: Between 2010 and 2015, the clinical information of patients with MRCC was selected using the Surveillance, Ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zhaoxiang, He, Wei, Zhou, Jun, Yang, Cheng, Xiang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218494/
https://www.ncbi.nlm.nih.gov/pubmed/35726570
http://dx.doi.org/10.1177/03000605221105367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218494/
https://www.ncbi.nlm.nih.gov/pubmed/35726570
http://dx.doi.org/10.1177/03000605221105367

Ejemplares similares